Guided Therapeutics, Inc. (OTCMKTS:GTHP) Short Interest Update

Guided Therapeutics, Inc. (OTCMKTS:GTHP) saw a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 13,800 shares, a growth of 40.8% from the January 31st total of 9,800 shares. Based on an average daily volume of 28,200 shares, the short-interest ratio is presently 0.5 days.

Guided Therapeutics Stock Performance

OTCMKTS GTHP traded down $0.01 during trading hours on Wednesday, reaching $0.10. The company’s stock had a trading volume of 28,256 shares, compared to its average volume of 17,319. The stock has a market cap of $6.25 million, a PE ratio of -3.19 and a beta of 0.61. The company’s 50-day moving average is $0.13 and its two-hundred day moving average is $0.15. Guided Therapeutics has a fifty-two week low of $0.06 and a fifty-two week high of $0.23.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.